董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Heidi G. Miller | 女 | Director | 72 | 27.59万美元 | 7.45 | 2026-03-02 |
| Eric C. Liu | 男 | Director | 50 | 未披露 | 未持股 | 2026-03-02 |
| Ethan Waxman | 男 | Director | 38 | 未披露 | 未持股 | 2026-03-02 |
| Vivian E. Riefberg | 女 | Director | 65 | 27.34万美元 | 1.68 | 2026-03-02 |
| Lauren Young | 女 | Director | 43 | 未披露 | 未持股 | 2026-03-02 |
| Aashima Gupta | 女 | Director | 55 | 23.59万美元 | 未持股 | 2026-03-02 |
| John Driscoll | 男 | Chairman of the Board | 67 | 36.34万美元 | 30.52 | 2026-03-02 |
| Matthew J. Hawkins | 男 | Chief Executive Officer and Director | 55 | 3712.43万美元 | 405.07 | 2026-03-02 |
| Robert A. DeMichiei | 男 | Director | 61 | 27.84万美元 | 11.18 | 2026-03-02 |
| Paul G. Moskowitz | 男 | Director | 39 | 未披露 | 未持股 | 2026-03-02 |
| Samuel Blaichman | 男 | Director | 50 | 未披露 | 未持股 | 2026-03-02 |
| Michael Roman | 男 | Director | 66 | 23.84万美元 | 未持股 | 2026-03-02 |
| Priscilla Hung | 女 | Director | 59 | 27.84万美元 | 1.68 | 2026-03-02 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Matthew J. Hawkins | 男 | Chief Executive Officer and Director | 55 | 3712.43万美元 | 405.07 | 2026-03-02 |
| T. Craig Bridge | 男 | Chief Transformation Officer | 54 | 1095.13万美元 | 未持股 | 2026-03-02 |
| Melissa F. Miller | 女 | Chief Marketing Officer | 41 | 未披露 | 未持股 | 2026-03-02 |
| Christopher L. Schremser | 男 | Chief Technology Officer | 55 | 1097.26万美元 | 66.54 | 2026-03-02 |
| Kim Wittman | 女 | Chief People Officer | 47 | 未披露 | 未持股 | 2026-03-02 |
| Greg Packer | 男 | Chief Legal Officer and Secretary | 46 | 未披露 | 未持股 | 2026-03-02 |
| Steven M. Oreskovich | 男 | Chief Financial Officer | 54 | 902.21万美元 | 未持股 | 2026-03-02 |
董事简历
中英对照 | 中文 | 英文- Heidi G. Miller
-
Heidi G. Miller，自2021年起担任Waystar Holding Corp.董事会成员。在2012年退休之前，她从2010年到2012年担任摩根大通国际（JPMorgan Chase & Co 。的一个部门）的总裁。此前，她从2004年到2010年担任摩根大通的财政和安全服务的首席执行官。Miller女士此前曾担任Bank One Corporation（被JPMorgan Chase收购）的执行副总裁兼首席财务官（2002年至2004年），并曾担任旅行者集团（一家多元化的金融服务公司）的首席财务官（1995年至1998年），以及花旗集团（一家投资银行和金融服务公司）的首席财务官（1998年至2001年）。Miller女士目前担任Fiserv（全球金融科技和支付公司）的董事会成员，此前曾担任HSBC Holdings PLC（银行和金融服务机构）的董事会成员（2014年至2021年），General Mills Inc.（食品服务制造商和包装消费品生产商）的董事会成员（1999年至2019年），Progressive Corp.（保险公司）的董事会成员（2011年至2014年），并担任国际财务报告标准基金会的受托人。制定会计和可持续性披露标准的非营利组织。
Heidi G. Miller,was president of JPMorgan International, a division of JPMorgan Chase & Co, from 2010 to 2012. Previously, Ms. Miller served as Chief Executive Officer of JPMorgan Chase's Treasury and Security Services from 2004 to 2010. Ms. Miller has previously served as Executive Vice President and Chief Financial Officer for Bank One Corporation, which was acquired by JPMorgan Chase, from 2002 to 2004, and has served as Chief Financial Officer for the Travelers Group, a diversified financial services company, from 1995 to 1998 and for Citigroup, an investment bank and financial services company, from 1998 to 2001. Ms. Miller currently serves on the board of Fiserv, a global fintech and payments company, and previously served on the boards of HSBC Holdings PLC, a banking and financial services institution, from 2014 to 2021, General Mills Inc., a food service manufacturer and producer of packaged consumer goods, from 1999 to 2019, and Progressive Corp., an insurance company, from 2011 to 2014, and as a trustee of the International Financial Reporting Standards Foundation, a not-for-profit organization that develops accounting and sustainability disclosure standards. - Heidi G. Miller，自2021年起担任Waystar Holding Corp.董事会成员。在2012年退休之前，她从2010年到2012年担任摩根大通国际（JPMorgan Chase & Co 。的一个部门）的总裁。此前，她从2004年到2010年担任摩根大通的财政和安全服务的首席执行官。Miller女士此前曾担任Bank One Corporation（被JPMorgan Chase收购）的执行副总裁兼首席财务官（2002年至2004年），并曾担任旅行者集团（一家多元化的金融服务公司）的首席财务官（1995年至1998年），以及花旗集团（一家投资银行和金融服务公司）的首席财务官（1998年至2001年）。Miller女士目前担任Fiserv（全球金融科技和支付公司）的董事会成员，此前曾担任HSBC Holdings PLC（银行和金融服务机构）的董事会成员（2014年至2021年），General Mills Inc.（食品服务制造商和包装消费品生产商）的董事会成员（1999年至2019年），Progressive Corp.（保险公司）的董事会成员（2011年至2014年），并担任国际财务报告标准基金会的受托人。制定会计和可持续性披露标准的非营利组织。
- Heidi G. Miller,was president of JPMorgan International, a division of JPMorgan Chase & Co, from 2010 to 2012. Previously, Ms. Miller served as Chief Executive Officer of JPMorgan Chase's Treasury and Security Services from 2004 to 2010. Ms. Miller has previously served as Executive Vice President and Chief Financial Officer for Bank One Corporation, which was acquired by JPMorgan Chase, from 2002 to 2004, and has served as Chief Financial Officer for the Travelers Group, a diversified financial services company, from 1995 to 1998 and for Citigroup, an investment bank and financial services company, from 1998 to 2001. Ms. Miller currently serves on the board of Fiserv, a global fintech and payments company, and previously served on the boards of HSBC Holdings PLC, a banking and financial services institution, from 2014 to 2021, General Mills Inc., a food service manufacturer and producer of packaged consumer goods, from 1999 to 2019, and Progressive Corp., an insurance company, from 2011 to 2014, and as a trustee of the International Financial Reporting Standards Foundation, a not-for-profit organization that develops accounting and sustainability disclosure standards.
- Eric C. Liu
-
Eric C.Liu自2017年起担任董事。Liu先生自2014年7月起担任另类资产管理公司EQT的合伙人兼梦百合全球联席主管。Liu先生目前担任Aldevron，LLC（一家合同制造和科学服务公司）和Waystar，Inc.（一家梦百合收入周期管理公司）的董事。
Eric C. Liu,has served as Partner, Co-Head of Private Capital and Global Co-Head of Healthcare at EQT, an alternative asset management firm, since 2014. Since 2024, he has also served as Executive Officer and a member of the board of directors of EQT Private Equity Company LLC, a holding company sponsored by EQT. Mr. Liu also currently serves on the board of Parexel, a global clinical research organization and biopharmaceutical services company, since 2021, and Zeus Industrial Products, Inc., a supplier of custom components to the medical device industry, since 2024. Mr. Liu was previously on the boards of Certara, a leader in model-informed drug development and regulatory science, from 2017 to 2022, Aldevron, a global supplier of plasmid DNA Waystar Holding Corp. ed in cell and gene therapies, from 2019 to 2021, and Press Ganey, a provider of healthcare measurement, performance analytics, and strategic advisory solutions, from 2016 to 2019. - Eric C.Liu自2017年起担任董事。Liu先生自2014年7月起担任另类资产管理公司EQT的合伙人兼梦百合全球联席主管。Liu先生目前担任Aldevron，LLC（一家合同制造和科学服务公司）和Waystar，Inc.（一家梦百合收入周期管理公司）的董事。
- Eric C. Liu,has served as Partner, Co-Head of Private Capital and Global Co-Head of Healthcare at EQT, an alternative asset management firm, since 2014. Since 2024, he has also served as Executive Officer and a member of the board of directors of EQT Private Equity Company LLC, a holding company sponsored by EQT. Mr. Liu also currently serves on the board of Parexel, a global clinical research organization and biopharmaceutical services company, since 2021, and Zeus Industrial Products, Inc., a supplier of custom components to the medical device industry, since 2024. Mr. Liu was previously on the boards of Certara, a leader in model-informed drug development and regulatory science, from 2017 to 2022, Aldevron, a global supplier of plasmid DNA Waystar Holding Corp. ed in cell and gene therapies, from 2019 to 2021, and Press Ganey, a provider of healthcare measurement, performance analytics, and strategic advisory solutions, from 2016 to 2019.
- Ethan Waxman
-
Ethan Waxman自2020年8月起担任董事。Waxman先生自2015年8月起在EQT担任董事。Waxman先生此前曾于2017年8月至2020年8月担任董事会观察员。Waxman先生于2017年6月至2020年10月担任公司和我们某些子公司的非雇员执行官。
Ethan Waxman,serves as a Partner at EQT, where he has worked since August 2015. Mr. Waxman currently serves on the board of Zeus Industrial Products, Inc., a supplier of custom components to the medical device industry, since 2024, and previously served on the board of Certara, Inc., a leading provider of software and scientific consulting services, from August 2020 to December 2022. - Ethan Waxman自2020年8月起担任董事。Waxman先生自2015年8月起在EQT担任董事。Waxman先生此前曾于2017年8月至2020年8月担任董事会观察员。Waxman先生于2017年6月至2020年10月担任公司和我们某些子公司的非雇员执行官。
- Ethan Waxman,serves as a Partner at EQT, where he has worked since August 2015. Mr. Waxman currently serves on the board of Zeus Industrial Products, Inc., a supplier of custom components to the medical device industry, since 2024, and previously served on the board of Certara, Inc., a leading provider of software and scientific consulting services, from August 2020 to December 2022.
- Vivian E. Riefberg
-
Vivian E.Riefberg自2020年2月起担任公司董事。自2020年8月以来，她一直担任David C.Walentas Jefferson Scholars Foundation教授职位，并担任弗吉尼亚大学达顿商学院的实践教授。在此之前，Riefberg女士于1987年9月至2020年5月在麦肯锡公司（McKinsey&Company）任职，并担任多个高级职位，包括领导美洲的公共部门实践并共同领导美国医疗保健实践。她目前自2020年6月起担任麦肯锡公司（McKinsey&Company）的名誉董事兼高级顾问。2018年，Riefberg女士当选为公共广播服务董事会董事。自2020年7月起，她还担任约翰·霍普金斯医学公司董事会成员。她此前曾担任the NIH Clinical Center的董事会成员，以及the Partnership for a Health America，Mentors，Inc.和McKinsey&Company的董事。Riefberg女士拥有Harvard Business School工商管理硕士学位和Harvard University历史学学士学位。
Vivian E. Riefberg,has served as a member of Waystar Holding Corp. board of directors since October 2023. Since August 2020, she has also served as the David C. Walentas Jefferson Scholars Foundation Professorship Chair and is a Professor of Practice at the University of Virginia ("UVA") Darden School of Business and a Fellow at The Miller Center at UVA. Ms. Riefberg previously held a variety of high-ranking executive positions at McKinsey & Company from September 1987 to July 1988 and December 1989 to May 2020, including leading the Public Sector Practice for the Americas and co-leading the U.S. Health Care practice. She also currently serves on the boards of ONWARD Medical N.V. since 2022 and Lightrock, an impact investing fund, since 2022 and privately held Accompany Health, Inc. since 2023 and K Health Inc. since 2021, and has served as an Emeritus Director with McKinsey & Company since June 2020. In the non-profit world, she serves on the boards of the Public Broadcasting Service since 2018, Johns Hopkins Medicine since July 2020, and the advisory board for the Smithsonian American Women's History Museum since August 2021. She was previously on the board of governors for the NIH Clinical Center from 2000 to 2004 and was a director on the boards for Signify Health, Inc. from 2020 to 2023, the Partnership for a Healthier America, and McKinsey & Company. - Vivian E.Riefberg自2020年2月起担任公司董事。自2020年8月以来，她一直担任David C.Walentas Jefferson Scholars Foundation教授职位，并担任弗吉尼亚大学达顿商学院的实践教授。在此之前，Riefberg女士于1987年9月至2020年5月在麦肯锡公司（McKinsey&Company）任职，并担任多个高级职位，包括领导美洲的公共部门实践并共同领导美国医疗保健实践。她目前自2020年6月起担任麦肯锡公司（McKinsey&Company）的名誉董事兼高级顾问。2018年，Riefberg女士当选为公共广播服务董事会董事。自2020年7月起，她还担任约翰·霍普金斯医学公司董事会成员。她此前曾担任the NIH Clinical Center的董事会成员，以及the Partnership for a Health America，Mentors，Inc.和McKinsey&Company的董事。Riefberg女士拥有Harvard Business School工商管理硕士学位和Harvard University历史学学士学位。
- Vivian E. Riefberg,has served as a member of Waystar Holding Corp. board of directors since October 2023. Since August 2020, she has also served as the David C. Walentas Jefferson Scholars Foundation Professorship Chair and is a Professor of Practice at the University of Virginia ("UVA") Darden School of Business and a Fellow at The Miller Center at UVA. Ms. Riefberg previously held a variety of high-ranking executive positions at McKinsey & Company from September 1987 to July 1988 and December 1989 to May 2020, including leading the Public Sector Practice for the Americas and co-leading the U.S. Health Care practice. She also currently serves on the boards of ONWARD Medical N.V. since 2022 and Lightrock, an impact investing fund, since 2022 and privately held Accompany Health, Inc. since 2023 and K Health Inc. since 2021, and has served as an Emeritus Director with McKinsey & Company since June 2020. In the non-profit world, she serves on the boards of the Public Broadcasting Service since 2018, Johns Hopkins Medicine since July 2020, and the advisory board for the Smithsonian American Women's History Museum since August 2021. She was previously on the board of governors for the NIH Clinical Center from 2000 to 2004 and was a director on the boards for Signify Health, Inc. from 2020 to 2023, the Partnership for a Healthier America, and McKinsey & Company.
- Lauren Young
-
Lauren Young自2019年7月起担任公司董事会成员。Young女士是Advent International Corporation（一家私人股本公司，专注于五个核心部门的投资:商业和金融服务；医疗保健；工业；零售、消费者和休闲；技术）的董事总经理。杨女士于2011年加入公司。在Advent之前，2006年至2009年，Young女士是美国跨国私人股本、另类资产管理和金融服务公司The Carlyle Group的美国收购基金成员，2004年至2006年，担任McColl Partners的分析师。Young女士目前还担任Forescout Technologies和P2Energy Solutions的董事会成员。此外，Young女士还担任CCC Intelligent Solutions Holdings Inc.（一家上市公司）的董事会成员。杨女士拥有戴维森学院（Davidson College）的学士学位和哈佛商学院（Harvard Business School）的MBA学位。
Lauren Young has served as a member of the board of directors of the Company since July 2019.Ms. Young is a Managing Director of Advent International Corporation, a private equity firm that focuses on investments in five core sectors: business and financial services; healthcare; industrial; retail, consumer and leisure; and technology. Ms. Young joined the firm in 2011. Prior to Advent, Ms. Young was a member of the US buyout fund at The Carlyle Group, an American multinational private equity, alternative asset management and financial services corporation, from 2006 to 2009 and served as an analyst at McColl partners from 2004 to 2006. Ms. Young also currently serves on the board of directors of Forescout Technologies and P2 Energy Solutions. Additionally, Ms. Young serves on the board of directors of CCC Intelligent Solutions Holdings Inc., a public company. Ms. Young holds a B.A. from Davidson College and an M.B.A. from the Harvard Business School. - Lauren Young自2019年7月起担任公司董事会成员。Young女士是Advent International Corporation（一家私人股本公司，专注于五个核心部门的投资:商业和金融服务；医疗保健；工业；零售、消费者和休闲；技术）的董事总经理。杨女士于2011年加入公司。在Advent之前，2006年至2009年，Young女士是美国跨国私人股本、另类资产管理和金融服务公司The Carlyle Group的美国收购基金成员，2004年至2006年，担任McColl Partners的分析师。Young女士目前还担任Forescout Technologies和P2Energy Solutions的董事会成员。此外，Young女士还担任CCC Intelligent Solutions Holdings Inc.（一家上市公司）的董事会成员。杨女士拥有戴维森学院（Davidson College）的学士学位和哈佛商学院（Harvard Business School）的MBA学位。
- Lauren Young has served as a member of the board of directors of the Company since July 2019.Ms. Young is a Managing Director of Advent International Corporation, a private equity firm that focuses on investments in five core sectors: business and financial services; healthcare; industrial; retail, consumer and leisure; and technology. Ms. Young joined the firm in 2011. Prior to Advent, Ms. Young was a member of the US buyout fund at The Carlyle Group, an American multinational private equity, alternative asset management and financial services corporation, from 2006 to 2009 and served as an analyst at McColl partners from 2004 to 2006. Ms. Young also currently serves on the board of directors of Forescout Technologies and P2 Energy Solutions. Additionally, Ms. Young serves on the board of directors of CCC Intelligent Solutions Holdings Inc., a public company. Ms. Young holds a B.A. from Davidson College and an M.B.A. from the Harvard Business School.
- Aashima Gupta
-
Aashima Gupta在通过技术转型推动业务增长、差异化和改善方面拥有超过25年的经验。目前，Gupta女士在Google Cloud担任医疗垂直领域的全球总监，在那里她领导跨提供者和付款人的GenAI战略，在行业需求和新技术的动态交叉中导航。在加入Google之前，Gupta女士曾在多个组织从事技术开发工作，包括NIIT、Fidelity Investments、J.P. Morgan Chase、Apigee和Kaiser Permanente。她的经验涉及相关细分市场、技术、地域和业务职能。除了强大的技术和领导能力，她还拥有两项计算机应用专利。
Aashima Gupta has over 25 years of experience in driving business growth, differentiation, and improvement through technology transformation. Currently, Ms. Gupta serves as Global Director for the healthcare vertical at Google Cloud, where she leads the GenAI strategy across Providers and Payers, navigating the dynamic intersection of industry needs and new technologies.Prior to joining Google, Ms. Gupta worked in technology development across a number of organizations, including NIIT, Fidelity Investments, J.P. Morgan Chase, Apigee, and Kaiser Permanente. Her experience spans relevant market segments, technologies, geographies, and business functions. In addition to her strong technical and leadership skills, she holds two patents in computer applications. - Aashima Gupta在通过技术转型推动业务增长、差异化和改善方面拥有超过25年的经验。目前，Gupta女士在Google Cloud担任医疗垂直领域的全球总监，在那里她领导跨提供者和付款人的GenAI战略，在行业需求和新技术的动态交叉中导航。在加入Google之前，Gupta女士曾在多个组织从事技术开发工作，包括NIIT、Fidelity Investments、J.P. Morgan Chase、Apigee和Kaiser Permanente。她的经验涉及相关细分市场、技术、地域和业务职能。除了强大的技术和领导能力，她还拥有两项计算机应用专利。
- Aashima Gupta has over 25 years of experience in driving business growth, differentiation, and improvement through technology transformation. Currently, Ms. Gupta serves as Global Director for the healthcare vertical at Google Cloud, where she leads the GenAI strategy across Providers and Payers, navigating the dynamic intersection of industry needs and new technologies.Prior to joining Google, Ms. Gupta worked in technology development across a number of organizations, including NIIT, Fidelity Investments, J.P. Morgan Chase, Apigee, and Kaiser Permanente. Her experience spans relevant market segments, technologies, geographies, and business functions. In addition to her strong technical and leadership skills, she holds two patents in computer applications.
- John Driscoll
-
John Driscoll，自2022年10月起担任美国医疗保健执行副总裁兼总裁，当时公司达成最终协议，收购CareCentrix（急性后和家庭护理管理部门的参与者）的全部所有权，在那里他担任首席执行官（2013年5月至2022年10月）。在此之前，他从2012年7月到2013年5月担任医疗保健技术公司Castlight Health的总裁，从2003年6月到2012年4月担任Medco Health Solutions的新市场集团总裁。在职业生涯早期，他是Oxford Health Plans的执行团队成员，担任政府项目的公司副总裁。
John Driscoll,currently serves as Chair of the board of directors of the Magnit Company, which he joined in November 2024. Previously, Mr. Driscoll served as President, U.S. Healthcare and Executive Vice President of Walgreens Boots Alliance Inc, from 2022 to 2024, as Chief Executive Officer of CareCentrix, a healthcare benefits management company, from 2013 to 2022, as President of Castlight Health, a healthcare technology company, from 2012 to 2013, and as Group President for Medco, a pharmacy benefits management company, from June 2003 to April 2012. Mr. Driscoll also previously founded and chaired the Surescripts ePrescribing Network, a national health information network, from 2004 to 2007, served as Advisor to Oak Investment Partners, a venture capital firm, and served as Vice President for government programs at Oxford Health Plans, a part of the UnitedHealthcare insurance company. Mr. Driscoll previously served on the board and as chair of the Audit Committee of Press Ganey, a provider of healthcare measurement, performance analytics, and strategic advisory solutions, from April 2016 to July 2019. - John Driscoll，自2022年10月起担任美国医疗保健执行副总裁兼总裁，当时公司达成最终协议，收购CareCentrix（急性后和家庭护理管理部门的参与者）的全部所有权，在那里他担任首席执行官（2013年5月至2022年10月）。在此之前，他从2012年7月到2013年5月担任医疗保健技术公司Castlight Health的总裁，从2003年6月到2012年4月担任Medco Health Solutions的新市场集团总裁。在职业生涯早期，他是Oxford Health Plans的执行团队成员，担任政府项目的公司副总裁。
- John Driscoll,currently serves as Chair of the board of directors of the Magnit Company, which he joined in November 2024. Previously, Mr. Driscoll served as President, U.S. Healthcare and Executive Vice President of Walgreens Boots Alliance Inc, from 2022 to 2024, as Chief Executive Officer of CareCentrix, a healthcare benefits management company, from 2013 to 2022, as President of Castlight Health, a healthcare technology company, from 2012 to 2013, and as Group President for Medco, a pharmacy benefits management company, from June 2003 to April 2012. Mr. Driscoll also previously founded and chaired the Surescripts ePrescribing Network, a national health information network, from 2004 to 2007, served as Advisor to Oak Investment Partners, a venture capital firm, and served as Vice President for government programs at Oxford Health Plans, a part of the UnitedHealthcare insurance company. Mr. Driscoll previously served on the board and as chair of the Audit Committee of Press Ganey, a provider of healthcare measurement, performance analytics, and strategic advisory solutions, from April 2016 to July 2019.
- Matthew J. Hawkins
-
马修·J·霍金斯自2017年10月起担任Waystar Holding Corp.首席执行官和Waystar Holding Corp.董事会成员。在加入Waystar Holding Corp.之前，霍金斯于2014年5月至2017年10月在医学实验室和诊断软件开发商Sunquest Information Systems担任总裁。霍金斯先生以前是私人股本公司Vista Equity Partners的运营负责人，曾担任卫生信息技术供应商Greenway Health的总裁和董事会成员，Vitera Healthcare Solutions的首席执行官和董事会成员，Vitera Healthcare Solutions是一家提供EHR、PM系统、财务和临床交易处理的公司，以及图书馆软件自动化公司SirsiDynix的首席执行官和董事会成员。2004年至2007年，霍金斯先生担任亨利香恩服务实践解决方案公司副总裁兼总经理，该公司是一家全球医疗保健分销公司。
Matthew J. Hawkins,was at Sunquest Information Systems, a developer of medical laboratory and diagnostic software, from May 2014 to October 2017, where he served as President. Mr. Hawkins was previously an operational leader with Vista Equity Partners, a private equity firm, where he served as President and board member of Greenway Health, a vendor of health information technology, Chief Executive Officer and board member of Vitera Healthcare Solutions, a provider of EHR, PM systems, and financial and clinical transaction processing, and Chief Executive Officer and board member of SirsiDynix, a library software automation company. From 2004 to 2007, Mr. Hawkins was Vice President and General Manager of Henry Schein Practice Solutions, a global health care distribution company. - 马修·J·霍金斯自2017年10月起担任Waystar Holding Corp.首席执行官和Waystar Holding Corp.董事会成员。在加入Waystar Holding Corp.之前，霍金斯于2014年5月至2017年10月在医学实验室和诊断软件开发商Sunquest Information Systems担任总裁。霍金斯先生以前是私人股本公司Vista Equity Partners的运营负责人，曾担任卫生信息技术供应商Greenway Health的总裁和董事会成员，Vitera Healthcare Solutions的首席执行官和董事会成员，Vitera Healthcare Solutions是一家提供EHR、PM系统、财务和临床交易处理的公司，以及图书馆软件自动化公司SirsiDynix的首席执行官和董事会成员。2004年至2007年，霍金斯先生担任亨利香恩服务实践解决方案公司副总裁兼总经理，该公司是一家全球医疗保健分销公司。
- Matthew J. Hawkins,was at Sunquest Information Systems, a developer of medical laboratory and diagnostic software, from May 2014 to October 2017, where he served as President. Mr. Hawkins was previously an operational leader with Vista Equity Partners, a private equity firm, where he served as President and board member of Greenway Health, a vendor of health information technology, Chief Executive Officer and board member of Vitera Healthcare Solutions, a provider of EHR, PM systems, and financial and clinical transaction processing, and Chief Executive Officer and board member of SirsiDynix, a library software automation company. From 2004 to 2007, Mr. Hawkins was Vice President and General Manager of Henry Schein Practice Solutions, a global health care distribution company.
- Robert A. DeMichiei
-
Robert A. DeMichiei，自2020年起担任Waystar Holding Corp.董事会成员。2004年至2020年，他担任UPMC的执行副总裁兼首席财务官。UPMC是一家非营利性医疗体系，也是领先的医疗保健提供者和保险公司。在加入UPMC之前，DeMichiei先生曾于1997年至2004年在设备、解决方案和服务供应商通用电气公司担任过各种行政职务，并于1987年至1997年在专业服务公司网络普华永道担任过各种职务。DeMichiei先生目前是Ampco Pittsburgh Corporation的董事会成员，该公司是一家制造锻造和铸造工程产品以及空气和液体加工产品的公司，以及南加州汽车俱乐部，这是一家全国性保险公司和会员服务组织，也是AAA汽车俱乐部联合会的一部分。DeMichiei先生目前还担任Health Catalyst和Omega Healthcare管理服务的战略顾问。他是Prodigo Solutions，Inc.的创始人和前董事会成员。他是宾夕法尼亚州西南部联合之路的前主席和现任董事会成员，Seton Hill大学董事会财务委员会主席，高级领导学院财务主管和财务委员会主席，这些都是慈善组织。
Robert A. DeMichiei,was the Executive Vice President and Chief Financial Officer of UPMC, a nonprofit health system and leading health care provider and insurer, from 2004 to 2020. Prior to joining UPMC, Mr. DeMichiei held various executive roles with the General Electric Company, an equipment, solutions, and services provider, from 1997 to 2004 and with PricewaterhouseCoopers, a network of professional services firms, from 1987 to 1997. Mr. DeMichiei currently serves as board member of Ampco Pittsburgh Corporation, a manufacturer of forged and cast engineered products and air and liquid processing products, the Automobile Club of Southern California, a national insurer and member services organization and a part of the AAA federation of motor clubs, and Ardent Health, a provider of healthcare in mid-sized urban communities across the U.S. Mr. DeMichiei also currently serves as a strategic advisor for Health Catalyst and Omega Healthcare Management Services. He was a founder and former board member of Prodigo Solutions, Inc. He is the former Chairman and a current board member of the United Way of Southwestern Pennsylvania, the Finance Committee Chair of the Seton Hill University Board of Trustees, and the Treasurer and Finance Committee Chair of the Advanced Leadership Institute, all charitable organizations. - Robert A. DeMichiei，自2020年起担任Waystar Holding Corp.董事会成员。2004年至2020年，他担任UPMC的执行副总裁兼首席财务官。UPMC是一家非营利性医疗体系，也是领先的医疗保健提供者和保险公司。在加入UPMC之前，DeMichiei先生曾于1997年至2004年在设备、解决方案和服务供应商通用电气公司担任过各种行政职务，并于1987年至1997年在专业服务公司网络普华永道担任过各种职务。DeMichiei先生目前是Ampco Pittsburgh Corporation的董事会成员，该公司是一家制造锻造和铸造工程产品以及空气和液体加工产品的公司，以及南加州汽车俱乐部，这是一家全国性保险公司和会员服务组织，也是AAA汽车俱乐部联合会的一部分。DeMichiei先生目前还担任Health Catalyst和Omega Healthcare管理服务的战略顾问。他是Prodigo Solutions，Inc.的创始人和前董事会成员。他是宾夕法尼亚州西南部联合之路的前主席和现任董事会成员，Seton Hill大学董事会财务委员会主席，高级领导学院财务主管和财务委员会主席，这些都是慈善组织。
- Robert A. DeMichiei,was the Executive Vice President and Chief Financial Officer of UPMC, a nonprofit health system and leading health care provider and insurer, from 2004 to 2020. Prior to joining UPMC, Mr. DeMichiei held various executive roles with the General Electric Company, an equipment, solutions, and services provider, from 1997 to 2004 and with PricewaterhouseCoopers, a network of professional services firms, from 1987 to 1997. Mr. DeMichiei currently serves as board member of Ampco Pittsburgh Corporation, a manufacturer of forged and cast engineered products and air and liquid processing products, the Automobile Club of Southern California, a national insurer and member services organization and a part of the AAA federation of motor clubs, and Ardent Health, a provider of healthcare in mid-sized urban communities across the U.S. Mr. DeMichiei also currently serves as a strategic advisor for Health Catalyst and Omega Healthcare Management Services. He was a founder and former board member of Prodigo Solutions, Inc. He is the former Chairman and a current board member of the United Way of Southwestern Pennsylvania, the Finance Committee Chair of the Seton Hill University Board of Trustees, and the Treasurer and Finance Committee Chair of the Advanced Leadership Institute, all charitable organizations.
- Paul G. Moskowitz
-
保罗·G·莫斯科维茨自2019年起担任Waystar Holding Corp.董事会成员，自2016年起担任董事会观察员。他是全球另类资产管理公司贝恩资本的董事总经理，他于2011年加入该公司。在加入贝恩资本之前，莫斯科维茨曾于2009年至2011年在全球咨询公司贝恩公司担任顾问。莫斯科维茨还在HCIT软件公司LeanTaas和PartsSource的董事会任职，后者是Waystar Holding Corp.的先进数据科学，旨在提高医院和诊所的运营绩效。PartsSource是一个在线B2B市场，供医院采购医疗技术设备零件和维护服务。
Paul G. Moskowitz,is a Managing Director at Bain Capital, a global alternative asset management firm, which he joined in 2011. Prior to joining Bain Capital, Mr. Moskowitz was a consultant at Bain & Company, a global consulting firm, from 2009 to 2011. Mr. Moskowitz also serves on the boards of LeanTaas, a HCIT software company that Waystar Holding Corp. es advanced data science to improve the operational performance of hospitals and clinics, and PartsSource, which is an online B2B marketplace for hospitals to procure medtech equipment parts and maintenance services. - 保罗·G·莫斯科维茨自2019年起担任Waystar Holding Corp.董事会成员，自2016年起担任董事会观察员。他是全球另类资产管理公司贝恩资本的董事总经理，他于2011年加入该公司。在加入贝恩资本之前，莫斯科维茨曾于2009年至2011年在全球咨询公司贝恩公司担任顾问。莫斯科维茨还在HCIT软件公司LeanTaas和PartsSource的董事会任职，后者是Waystar Holding Corp.的先进数据科学，旨在提高医院和诊所的运营绩效。PartsSource是一个在线B2B市场，供医院采购医疗技术设备零件和维护服务。
- Paul G. Moskowitz,is a Managing Director at Bain Capital, a global alternative asset management firm, which he joined in 2011. Prior to joining Bain Capital, Mr. Moskowitz was a consultant at Bain & Company, a global consulting firm, from 2009 to 2011. Mr. Moskowitz also serves on the boards of LeanTaas, a HCIT software company that Waystar Holding Corp. es advanced data science to improve the operational performance of hospitals and clinics, and PartsSource, which is an online B2B marketplace for hospitals to procure medtech equipment parts and maintenance services.
- Samuel Blaichman
-
Samuel Blaichman，自2024年4月起担任Waystar Holding Corp.董事会成员。他是CPPIB的董事总经理、北美地区主管，直接私募股权，他于2007年加入该公司。Blaichman先生此前曾在贝恩公司担任管理顾问，并在普华永道的企业融资和鉴证组任职。他目前担任专业风险承担组织Ascot Group、混合包装供应商Berlin Packaging、人寿保险公司Wilton Re的董事会成员，此前曾担任动力传送带和流体动力产品制造商Gates Corporation和空气分配和通风解决方案制造商Air Distribution Technologies的董事会成员。
Samuel Blaichman,is Managing Director, Head of Direct Private Equity at CPPIB, which he joined in 2007. Mr. Blaichman previously worked at Bain & Company as a management consultant and in the Corporate Finance and Assurance groups at PricewaterhouseCoopers. He currently serves on the board of Ascot Group, a specialty risk-assumption organization, and previously served on the boards of The Gates Corporation, a manufacturer of power transmission belts and fluid power products, Air Distribution Technologies, a manufacturer of air distribution and ventilation solutions, Wilton Re, a life insurance company, and Berlin Packaging, a hybrid packaging supplier. - Samuel Blaichman，自2024年4月起担任Waystar Holding Corp.董事会成员。他是CPPIB的董事总经理、北美地区主管，直接私募股权，他于2007年加入该公司。Blaichman先生此前曾在贝恩公司担任管理顾问，并在普华永道的企业融资和鉴证组任职。他目前担任专业风险承担组织Ascot Group、混合包装供应商Berlin Packaging、人寿保险公司Wilton Re的董事会成员，此前曾担任动力传送带和流体动力产品制造商Gates Corporation和空气分配和通风解决方案制造商Air Distribution Technologies的董事会成员。
- Samuel Blaichman,is Managing Director, Head of Direct Private Equity at CPPIB, which he joined in 2007. Mr. Blaichman previously worked at Bain & Company as a management consultant and in the Corporate Finance and Assurance groups at PricewaterhouseCoopers. He currently serves on the board of Ascot Group, a specialty risk-assumption organization, and previously served on the boards of The Gates Corporation, a manufacturer of power transmission belts and fluid power products, Air Distribution Technologies, a manufacturer of air distribution and ventilation solutions, Wilton Re, a life insurance company, and Berlin Packaging, a hybrid packaging supplier.
- Michael Roman
-
Michael Roman，1988年加入多元化技术和制造公司3M公司，曾担任过多种职务，最近一次是在2018年7月至2024年5月退休期间担任该公司的首席执行官。自2021年4月起，Roman先生担任雅培的董事会成员。Roman先生于2019年5月至2024年5月期间担任3M公司的董事会主席，随后于2024年5月至2025年3月期间担任该公司的执行主席。
Michael Roman,joined 3M Company, a diversified technology and manufacturing company, in 1988 where he served in a variety of roles, most recently as its chief executive officer from July 2018 until his retirement in May 2024. Since April 2021, Mr. Roman has served as a member of the board of directors of Abbott Laboratories. Mr. Roman served as chairman of the board of directors of 3M Company from May 2019 to May 2024 and then as its executive chairman from May 2024 to March 2025. - Michael Roman，1988年加入多元化技术和制造公司3M公司，曾担任过多种职务，最近一次是在2018年7月至2024年5月退休期间担任该公司的首席执行官。自2021年4月起，Roman先生担任雅培的董事会成员。Roman先生于2019年5月至2024年5月期间担任3M公司的董事会主席，随后于2024年5月至2025年3月期间担任该公司的执行主席。
- Michael Roman,joined 3M Company, a diversified technology and manufacturing company, in 1988 where he served in a variety of roles, most recently as its chief executive officer from July 2018 until his retirement in May 2024. Since April 2021, Mr. Roman has served as a member of the board of directors of Abbott Laboratories. Mr. Roman served as chairman of the board of directors of 3M Company from May 2019 to May 2024 and then as its executive chairman from May 2024 to March 2025.
- Priscilla Hung
-
Priscilla Hung曾担任Guidewire Software, Inc.自2020年6月起担任总裁，自2017年6月起担任首席运营官。她也曾担任Guidewire Software, Inc.2014年9月至2017年6月担任Guidewire Software, Inc.的首席行政官。2012年9月至2014年9月，担任运营和企业发展高级副总裁。2010年至2012年担任Guidewire Software, Inc.的运营副总裁。2005年至2010年担任企业发展和联盟副总裁。她目前是Vonage Holdings Corp.（一家上市的云通信供应商）的董事会成员。加入Guidewire之前，从2000年到2005年，她在Ariba Inc.担任多个管理职位，包括运营总监和全球渠道和联盟总监。Hung女士持有硕士学位。康奈尔大学工业工程和运筹学学位。
Priscilla Hung has served as a member of board of directors since April 2021. Ms. Hung previoly served as a Senior Advisor at Guidewire Software, Inc., a provider of cloud based software for the property and casualty insurance industry from January 2024 to June 2025. Prior to becoming a Senior Advisor, Ms. Hung held multiple executive roles at Guidewire since 2005, including president and chief operating officer, chief administrative officer, senior vice president of corporate development, vice president of operations, and vice president of corporate development. Prior to joining Guidewire, Ms. Hung held multiple management positions at SAP Ariba, a software and information technology services company, Sun Microsystems, Inc., a manufacturer of computer workstations, servers, and software, and Oracle Corporation, a database and enterprise management company. Ms. Hung has served on the board of Xerox Holdings Corporation (Nasdaq: XRX), a global leader in office systems and production print technology, since May 2024, where she serves on the corporate governance committee and finance committee, Veeva Systems Inc. (NYSE: VEEV), a provider of cloud based software for the global life sciences industry, since January 2022, where she serves on the audit committee, and Waystar Holding Corp. (Nasdaq: WAY), a leading enterprise healthcare payments company, since February 2024, where she serves on the audit, compliance, and risk committee and talent and compensation committee. Ms. Hung previoly served on the board of Vonage Holdings Corp., a cloud communications provider, from 2019 until 2022, when it was acquired by Telefonaktiebolaget LM Ericsson. Ms. Hung holds a Bachelor of Arts degree in Computer Science from Mills College and a Master of Engineering in Operation Research & Indtrial Engineering from Cornell University. Ms. Hung was selected to serve on board of directors becae of her experience serving on the boards of financial technology companies as ll as her corporate management experience. - Priscilla Hung曾担任Guidewire Software, Inc.自2020年6月起担任总裁，自2017年6月起担任首席运营官。她也曾担任Guidewire Software, Inc.2014年9月至2017年6月担任Guidewire Software, Inc.的首席行政官。2012年9月至2014年9月，担任运营和企业发展高级副总裁。2010年至2012年担任Guidewire Software, Inc.的运营副总裁。2005年至2010年担任企业发展和联盟副总裁。她目前是Vonage Holdings Corp.（一家上市的云通信供应商）的董事会成员。加入Guidewire之前，从2000年到2005年，她在Ariba Inc.担任多个管理职位，包括运营总监和全球渠道和联盟总监。Hung女士持有硕士学位。康奈尔大学工业工程和运筹学学位。
- Priscilla Hung has served as a member of board of directors since April 2021. Ms. Hung previoly served as a Senior Advisor at Guidewire Software, Inc., a provider of cloud based software for the property and casualty insurance industry from January 2024 to June 2025. Prior to becoming a Senior Advisor, Ms. Hung held multiple executive roles at Guidewire since 2005, including president and chief operating officer, chief administrative officer, senior vice president of corporate development, vice president of operations, and vice president of corporate development. Prior to joining Guidewire, Ms. Hung held multiple management positions at SAP Ariba, a software and information technology services company, Sun Microsystems, Inc., a manufacturer of computer workstations, servers, and software, and Oracle Corporation, a database and enterprise management company. Ms. Hung has served on the board of Xerox Holdings Corporation (Nasdaq: XRX), a global leader in office systems and production print technology, since May 2024, where she serves on the corporate governance committee and finance committee, Veeva Systems Inc. (NYSE: VEEV), a provider of cloud based software for the global life sciences industry, since January 2022, where she serves on the audit committee, and Waystar Holding Corp. (Nasdaq: WAY), a leading enterprise healthcare payments company, since February 2024, where she serves on the audit, compliance, and risk committee and talent and compensation committee. Ms. Hung previoly served on the board of Vonage Holdings Corp., a cloud communications provider, from 2019 until 2022, when it was acquired by Telefonaktiebolaget LM Ericsson. Ms. Hung holds a Bachelor of Arts degree in Computer Science from Mills College and a Master of Engineering in Operation Research & Indtrial Engineering from Cornell University. Ms. Hung was selected to serve on board of directors becae of her experience serving on the boards of financial technology companies as ll as her corporate management experience.
高管简历
中英对照 | 中文 | 英文- Matthew J. Hawkins
马修·J·霍金斯自2017年10月起担任Waystar Holding Corp.首席执行官和Waystar Holding Corp.董事会成员。在加入Waystar Holding Corp.之前，霍金斯于2014年5月至2017年10月在医学实验室和诊断软件开发商Sunquest Information Systems担任总裁。霍金斯先生以前是私人股本公司Vista Equity Partners的运营负责人，曾担任卫生信息技术供应商Greenway Health的总裁和董事会成员，Vitera Healthcare Solutions的首席执行官和董事会成员，Vitera Healthcare Solutions是一家提供EHR、PM系统、财务和临床交易处理的公司，以及图书馆软件自动化公司SirsiDynix的首席执行官和董事会成员。2004年至2007年，霍金斯先生担任亨利香恩服务实践解决方案公司副总裁兼总经理，该公司是一家全球医疗保健分销公司。
Matthew J. Hawkins,was at Sunquest Information Systems, a developer of medical laboratory and diagnostic software, from May 2014 to October 2017, where he served as President. Mr. Hawkins was previously an operational leader with Vista Equity Partners, a private equity firm, where he served as President and board member of Greenway Health, a vendor of health information technology, Chief Executive Officer and board member of Vitera Healthcare Solutions, a provider of EHR, PM systems, and financial and clinical transaction processing, and Chief Executive Officer and board member of SirsiDynix, a library software automation company. From 2004 to 2007, Mr. Hawkins was Vice President and General Manager of Henry Schein Practice Solutions, a global health care distribution company.- 马修·J·霍金斯自2017年10月起担任Waystar Holding Corp.首席执行官和Waystar Holding Corp.董事会成员。在加入Waystar Holding Corp.之前，霍金斯于2014年5月至2017年10月在医学实验室和诊断软件开发商Sunquest Information Systems担任总裁。霍金斯先生以前是私人股本公司Vista Equity Partners的运营负责人，曾担任卫生信息技术供应商Greenway Health的总裁和董事会成员，Vitera Healthcare Solutions的首席执行官和董事会成员，Vitera Healthcare Solutions是一家提供EHR、PM系统、财务和临床交易处理的公司，以及图书馆软件自动化公司SirsiDynix的首席执行官和董事会成员。2004年至2007年，霍金斯先生担任亨利香恩服务实践解决方案公司副总裁兼总经理，该公司是一家全球医疗保健分销公司。
- Matthew J. Hawkins,was at Sunquest Information Systems, a developer of medical laboratory and diagnostic software, from May 2014 to October 2017, where he served as President. Mr. Hawkins was previously an operational leader with Vista Equity Partners, a private equity firm, where he served as President and board member of Greenway Health, a vendor of health information technology, Chief Executive Officer and board member of Vitera Healthcare Solutions, a provider of EHR, PM systems, and financial and clinical transaction processing, and Chief Executive Officer and board member of SirsiDynix, a library software automation company. From 2004 to 2007, Mr. Hawkins was Vice President and General Manager of Henry Schein Practice Solutions, a global health care distribution company.
- T. Craig Bridge
T·克雷格·布里奇自2019年10月起担任Waystar Holding Corp.首席转型官。在被任命担任这一职务之前，布里奇先生曾于2018年2月至2019年10月担任首席运营和整合官。在2001年1月与他人共同创立Navicure（即现在的Waystar）之前，布里奇曾在S2系统公司工作，该公司是一家为银行和金融市场提供综合解决方案的全球供应商，2000年至2001年期间，他负责项目管理和质量保证小组的工作。Bridge先生曾供职于NDCHealth的Provider Healthcare Transaction Group，这是一家提供医疗保健信息软件解决方案的公司，他曾在1994年至2000年期间担任过多个职位。
T. Craig Bridge,served as Chief Operating and Integration Officer from February 2018 to October 2019. Prior to co-founding Navicure, which is now known as Waystar, in January 2001, Mr. Bridge was at S2 Systems, a global provider of integrated solutions for banking and financial markets, where he oversaw Project Management and Quality Assurance Groups from 2000 to 2001. Mr. Bridge was previously at NDCHealth's Provider Healthcare Transaction Group, a provider of healthcare information software solutions, where he served in various positions from 1994 to 2000.- T·克雷格·布里奇自2019年10月起担任Waystar Holding Corp.首席转型官。在被任命担任这一职务之前，布里奇先生曾于2018年2月至2019年10月担任首席运营和整合官。在2001年1月与他人共同创立Navicure（即现在的Waystar）之前，布里奇曾在S2系统公司工作，该公司是一家为银行和金融市场提供综合解决方案的全球供应商，2000年至2001年期间，他负责项目管理和质量保证小组的工作。Bridge先生曾供职于NDCHealth的Provider Healthcare Transaction Group，这是一家提供医疗保健信息软件解决方案的公司，他曾在1994年至2000年期间担任过多个职位。
- T. Craig Bridge,served as Chief Operating and Integration Officer from February 2018 to October 2019. Prior to co-founding Navicure, which is now known as Waystar, in January 2001, Mr. Bridge was at S2 Systems, a global provider of integrated solutions for banking and financial markets, where he oversaw Project Management and Quality Assurance Groups from 2000 to 2001. Mr. Bridge was previously at NDCHealth's Provider Healthcare Transaction Group, a provider of healthcare information software solutions, where he served in various positions from 1994 to 2000.
- Melissa F. Miller
Melissa F. Miller自2023年1月起担任Waystar Holding Corp.首席营销官。在被任命为首席营销官之前，米勒女士曾于2021年12月至2023年2月担任Waystar Holding Corp.营销高级副总裁，并于2020年8月至2021年12月担任Waystar Holding Corp.商业化副总裁。在加入Waystar控股公司之前，米勒女士曾于2018年至2020年在混合咨询和营销服务公司Chameleon Collective担任临时首席增长官和首席营销官。米勒女士曾于2018年至2020年担任Frances and Company的所有者，该公司是一家为营销、商业和客户成功功能提供进入市场咨询的公司，并于2015年至2018年在ZirMed担任过各种职务，该公司现在是Waystar的一部分，2008年至2015年在McKesson Provider Technologies担任过各种职务，该公司提供医疗保健分销和技术服务。
Melissa F. Miller,served as Interim Chief Growth Officer and Chief Marketing Officer at Chameleon Collective, a hybrid consulting and marketing services firm, from 2018 to 2020. Ms. Miller was previously Owner of Frances and Company, a provider of go-to-market consulting for marketing, commercial, and client success functions, from 2018 to 2020, and has served in various roles at ZirMed, which is now a part of Waystar, from 2015 to 2018 and at McKesson Provider Technologies, which provides healthcare distribution and technology services, from 2008 to 2015.- Melissa F. Miller自2023年1月起担任Waystar Holding Corp.首席营销官。在被任命为首席营销官之前，米勒女士曾于2021年12月至2023年2月担任Waystar Holding Corp.营销高级副总裁，并于2020年8月至2021年12月担任Waystar Holding Corp.商业化副总裁。在加入Waystar控股公司之前，米勒女士曾于2018年至2020年在混合咨询和营销服务公司Chameleon Collective担任临时首席增长官和首席营销官。米勒女士曾于2018年至2020年担任Frances and Company的所有者，该公司是一家为营销、商业和客户成功功能提供进入市场咨询的公司，并于2015年至2018年在ZirMed担任过各种职务，该公司现在是Waystar的一部分，2008年至2015年在McKesson Provider Technologies担任过各种职务，该公司提供医疗保健分销和技术服务。
- Melissa F. Miller,served as Interim Chief Growth Officer and Chief Marketing Officer at Chameleon Collective, a hybrid consulting and marketing services firm, from 2018 to 2020. Ms. Miller was previously Owner of Frances and Company, a provider of go-to-market consulting for marketing, commercial, and client success functions, from 2018 to 2020, and has served in various roles at ZirMed, which is now a part of Waystar, from 2015 to 2018 and at McKesson Provider Technologies, which provides healthcare distribution and technology services, from 2008 to 2015.
- Christopher L. Schremser
Christopher L. Schremser自2017年11月起担任Waystar Holding Corp.首席技术官。在加入Waystar Holding Corp.之前，Schremser先生曾在ZirMed工作，该公司现在是Waystar的一部分，他曾于2002年至2017年担任首席技术官，并于2000年至2002年担任基础设施经理。
Christopher L. Schremser,was at ZirMed, which is now a part of Waystar, where he served as Chief Technology Officer from 2002 to 2017 and as Infrastructure Manager from 2000 to 2002.- Christopher L. Schremser自2017年11月起担任Waystar Holding Corp.首席技术官。在加入Waystar Holding Corp.之前，Schremser先生曾在ZirMed工作，该公司现在是Waystar的一部分，他曾于2002年至2017年担任首席技术官，并于2000年至2002年担任基础设施经理。
- Christopher L. Schremser,was at ZirMed, which is now a part of Waystar, where he served as Chief Technology Officer from 2002 to 2017 and as Infrastructure Manager from 2000 to 2002.
- Kim Wittman
Kim Wittman，自2024年3月起担任Waystar Holding Corp.首席人事官。在加入Waystar之前，Wittman女士在2022年至2024年期间担任智能家居和安全公司Vivint，Inc.的人与文化高级副总裁。在被任命为高级副总裁之前，Wittman女士自2013年加入公司以来曾在Vivint担任过多个职务，包括人才获取副总裁、技术和企业人力资源业务合伙人、人力资源高级总监、技术和企业人力资源总监、技术和企业人才获取经理以及高级校园招聘人员。在加入Vivint之前，Wittman女士曾担任过IT服务管理公司TEKSystems Inc.、零售公司Limited Brands，Inc.、百货公司梅西百货 Inc.以及时尚零售公司The Buckle, Inc.等多个职位。
Kim Wittman,served as Senior Vice President of People and Culture of Vivint, Inc., a smart home and security company, from 2022 until 2024. Prior to being named Senior Vice President, Ms. Wittman served in various roles at Vivint since she joined the Company in 2013, including Vice President of Talent Acquisition, HR Business Partner for Technology and Corporate, Senior Director of Human Resources, Director of Human Resources for Technology and Corporate, Manager of Talent Acquisition for Technology and Corporate, and Senior Campus Recruiter. Prior to joining Vivint, Ms. Wittman held various positions a TEKsystems Inc., an IT services management company, Limited Brands, Inc., a retail company, Macy's Inc., a department store company, and The Buckle, Inc., a fashion retail company.- Kim Wittman，自2024年3月起担任Waystar Holding Corp.首席人事官。在加入Waystar之前，Wittman女士在2022年至2024年期间担任智能家居和安全公司Vivint，Inc.的人与文化高级副总裁。在被任命为高级副总裁之前，Wittman女士自2013年加入公司以来曾在Vivint担任过多个职务，包括人才获取副总裁、技术和企业人力资源业务合伙人、人力资源高级总监、技术和企业人力资源总监、技术和企业人才获取经理以及高级校园招聘人员。在加入Vivint之前，Wittman女士曾担任过IT服务管理公司TEKSystems Inc.、零售公司Limited Brands，Inc.、百货公司梅西百货 Inc.以及时尚零售公司The Buckle, Inc.等多个职位。
- Kim Wittman,served as Senior Vice President of People and Culture of Vivint, Inc., a smart home and security company, from 2022 until 2024. Prior to being named Senior Vice President, Ms. Wittman served in various roles at Vivint since she joined the Company in 2013, including Vice President of Talent Acquisition, HR Business Partner for Technology and Corporate, Senior Director of Human Resources, Director of Human Resources for Technology and Corporate, Manager of Talent Acquisition for Technology and Corporate, and Senior Campus Recruiter. Prior to joining Vivint, Ms. Wittman held various positions a TEKsystems Inc., an IT services management company, Limited Brands, Inc., a retail company, Macy's Inc., a department store company, and The Buckle, Inc., a fashion retail company.
- Greg Packer
格雷格·帕克（Greg Packer）于2023年3月至2025年3月期间担任家族历史和消费者基因组学公司Ancestry的高级副总裁兼首席法务官。在被任命为Ancestry的首席法务官之前，Packer先生自2020年4月加入公司以来，在Ancestry担任过多个职务，包括总法律顾问和企业与证券副总裁。在加入Ancestry之前，Packer先生还担任过多个其他总法律顾问职位，包括在Lonestar Resources US Inc.和Howard Energy Partners LLC。
Greg Packer,served as Senior Vice President & Chief Legal Officer of Ancestry, a family history and consumer genomics company, from March 2023 until March 2025. Prior to being named as Chief Legal Officer at Ancestry, Mr. Packer held various roles at Ancestry from when he joined the company in April 2020, including General Counsel and VP, Corporate & Securities. Prior to joining Ancestry, Mr. Packer held multiple other General Counsel positions, including at Lonestar Resources US Inc., and Howard Energy Partners LLC.- 格雷格·帕克（Greg Packer）于2023年3月至2025年3月期间担任家族历史和消费者基因组学公司Ancestry的高级副总裁兼首席法务官。在被任命为Ancestry的首席法务官之前，Packer先生自2020年4月加入公司以来，在Ancestry担任过多个职务，包括总法律顾问和企业与证券副总裁。在加入Ancestry之前，Packer先生还担任过多个其他总法律顾问职位，包括在Lonestar Resources US Inc.和Howard Energy Partners LLC。
- Greg Packer,served as Senior Vice President & Chief Legal Officer of Ancestry, a family history and consumer genomics company, from March 2023 until March 2025. Prior to being named as Chief Legal Officer at Ancestry, Mr. Packer held various roles at Ancestry from when he joined the company in April 2020, including General Counsel and VP, Corporate & Securities. Prior to joining Ancestry, Mr. Packer held multiple other General Counsel positions, including at Lonestar Resources US Inc., and Howard Energy Partners LLC.
- Steven M. Oreskovich
Steven M. Oreskovich，于2008年6月被任命为财务总监和会计。2011年7月，他从财务总监调迁为首席会计官。Dearborn先生在2012年5月担任本公司Merge DNA业务部首席执行官之后，又再次担任财务总监。他在这段时期内继续担任本公司的会计。在2008年6月担任财务总监和会计之前，他自2007年1月以来担任本公司的内部审计副总裁；在2006年7月-2007年1月期间担任首席会计官和临时会计、临时秘书；2004年4月-2006年7月期间担任本公司副总裁和财务总监。在加入本公司之前，2000年4月-2003年1月期间，曾在一家为企业对企业电子商务企业提供客户智能解决方案的公司- Truis股份有限公司担任财务和运营副总裁。在那之前，他曾于1994年9月-2000年4月期间，在PricewaterhouseCoopers LLP担任审计师。Oreskovich先生拥有Marquette大学的会计学学士学位；他是一位注册会计师。
Steven M. Oreskovich,was at Merge Healthcare, a subsidiary of IBM through acquisition in 2015 and a software provider of medical image handling and processing, interoperability, and clinical systems, where he held various progressive financial roles, including Corporate Controller, Vice President, Internal Audit, Chief Accounting Officer, and Chief Financial Officer and Treasurer, from 2004 to 2017. Mr. Oreskovich also previously served in various financial roles at Truis, Inc. and at PricewaterhouseCoopers LLP, an accounting firm.- Steven M. Oreskovich，于2008年6月被任命为财务总监和会计。2011年7月，他从财务总监调迁为首席会计官。Dearborn先生在2012年5月担任本公司Merge DNA业务部首席执行官之后，又再次担任财务总监。他在这段时期内继续担任本公司的会计。在2008年6月担任财务总监和会计之前，他自2007年1月以来担任本公司的内部审计副总裁；在2006年7月-2007年1月期间担任首席会计官和临时会计、临时秘书；2004年4月-2006年7月期间担任本公司副总裁和财务总监。在加入本公司之前，2000年4月-2003年1月期间，曾在一家为企业对企业电子商务企业提供客户智能解决方案的公司- Truis股份有限公司担任财务和运营副总裁。在那之前，他曾于1994年9月-2000年4月期间，在PricewaterhouseCoopers LLP担任审计师。Oreskovich先生拥有Marquette大学的会计学学士学位；他是一位注册会计师。
- Steven M. Oreskovich,was at Merge Healthcare, a subsidiary of IBM through acquisition in 2015 and a software provider of medical image handling and processing, interoperability, and clinical systems, where he held various progressive financial roles, including Corporate Controller, Vice President, Internal Audit, Chief Accounting Officer, and Chief Financial Officer and Treasurer, from 2004 to 2017. Mr. Oreskovich also previously served in various financial roles at Truis, Inc. and at PricewaterhouseCoopers LLP, an accounting firm.